Healthcare

SeaStar Medical Expands QUELIMMUNE Adoption for Critically Ill Pediatric Patients with Acute Kidney Injury (AKI)

Nationally Recognized Texas Children’s Hospital Adds First-In-Class Therapy as a Potential Life-Saving Treatment in Ultra-Rare Cases of Pediatric AKIDENVER, July…

6 months ago

Alignment Healthcare Wins Key Legal Victory: Arizona Medicare Advantage Plans Elevated to 4 Stars

Court ruling means 100% of Alignment’s members now enrolled in plans rated 4 stars or greaterORANGE, Calif., July 08, 2025 (GLOBE…

6 months ago

Humacyte announces Symvess™ ECAT Approval from U.S. Defense Logistics Agency

Electronic Catalog listing approval makes Symvess available to healthcare professionals at U.S. Department of Defense and U.S. Department of Veterans…

6 months ago

Beacon Therapeutics completes enrollment in registrational Phase 2/3 VISTA trial of laru-zova for patients with XLRP

Topline data expected in H2 2026 LONDON and CAMBRIDGE, Mass., July 08, 2025 (GLOBE NEWSWIRE) -- Beacon Therapeutics Holdings Limited…

6 months ago

Medvantx Acquires RxS to Broaden Integrated Access & Engagement Solutions for Life Science

Combined company will leverage services and technology platforms to offer a broad portfolio of integrated solutions to pharmaceutical and device…

6 months ago

Eupraxia Doses First Patient in Phase 2b Placebo-Controlled Portion of EP-104GI RESOLVE Trial in Eosinophilic Esophagitis

Dosing of the first patient in Phase 2b marks an important transition of the RESOLVE trial from a Phase 2a…

6 months ago

Agios Appoints Dr. Jay Backstrom to Board of Directors

CAMBRIDGE, Mass., July 08, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and pyruvate…

6 months ago

WeightWatchers Completes Financial Reorganization, Strengthens Leadership, and Expands Program Innovation to Support Women Through Menopause

With renewed financial strength, WeightWatchers accelerates its transformation with the appointment of key executives including Dr. Kim Boyd as Chief…

6 months ago

UAE Approves BioAro’s Longevity+ Supplement, Signaling Major Market Potential in Global Preventive Health

With a patent-pending formula and international expansion underway, BioAro positions itself as a front-runner in the multi-billion-dollar longevity and wellness…

6 months ago

Novartis receives approval for first malaria medicine for newborn babies and young infants

Coartem® (artemether-lumefantrine) Baby becomes first malaria treatment approved for newborn babies and young infants Rapid approvals in eight African countries…

6 months ago